Founded in 2013 and based in San Diego, California, Arcturus Therapeutics is an industry leader in the application of RNA technologies for the treatment of disease and improved quality of life. The company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. Backed by a management team with extensive experience in the discovery and development of RNA medicines, Arcturus is on the forefront of research and development of RNA chemistry and delivery technologies.
March 11, 2018
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
March 9, 2018
Arcturus Therapeutics to Present at Bio Europe on March 13th
March 5, 2018
Arcturus Therapeutics Calls on Proposed Director Nominees to Respond to Constructive Board Outreach